Consolidated Statement Of Income

Delta-Fly Pharma, Inc. - Filing #7710878

Concept 2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Consolidated statement of income
Statement of income
Operating expenses
Selling, general and administrative expenses
Taxes and dues
36,098,000 JPY
9,762,000 JPY
Operating expenses
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
48,420,000 JPY
49,047,000 JPY
Ordinary profit (loss)
-671,213,000 JPY
-244,505,000 JPY
General and administrative expenses
Salaries
Operating profit (loss)
-592,523,000 JPY
-243,818,000 JPY
Selling, general and administrative expenses
Non-operating income
Interest income
283,000 JPY
222,000 JPY
Other
522,000 JPY
0 JPY
Non-operating income
806,000 JPY
805,000 JPY
Non-operating expenses
79,495,000 JPY
1,492,000 JPY
Interest expenses
312,000 JPY
442,000 JPY
Share issuance costs
15,414,000 JPY
1,050,000 JPY
Non-operating expenses
Other
876,000 JPY
JPY
Profit (loss) before income taxes
-671,213,000 JPY
-244,505,000 JPY
Income taxes - current
2,543,000 JPY
1,762,000 JPY
Income taxes
2,543,000 JPY
1,762,000 JPY
Profit (loss)
-673,756,000 JPY
-673,756,000 JPY
-673,756,000 JPY
-673,756,000 JPY
-246,268,000 JPY
-246,268,000 JPY
-246,268,000 JPY
-246,268,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.